AU2003245438A1 - Gene cluster analysis for coronary artery disease - Google Patents

Gene cluster analysis for coronary artery disease

Info

Publication number
AU2003245438A1
AU2003245438A1 AU2003245438A AU2003245438A AU2003245438A1 AU 2003245438 A1 AU2003245438 A1 AU 2003245438A1 AU 2003245438 A AU2003245438 A AU 2003245438A AU 2003245438 A AU2003245438 A AU 2003245438A AU 2003245438 A1 AU2003245438 A1 AU 2003245438A1
Authority
AU
Australia
Prior art keywords
coronary artery
artery disease
cluster analysis
gene cluster
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003245438A
Other versions
AU2003245438A8 (en
Inventor
Victoria L. M. Herrera
Nelson Ruiz-Opazo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mucosal Therapeutics LLC
Original Assignee
Mucosal Therapeutics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mucosal Therapeutics LLC filed Critical Mucosal Therapeutics LLC
Publication of AU2003245438A1 publication Critical patent/AU2003245438A1/en
Publication of AU2003245438A8 publication Critical patent/AU2003245438A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2003245438A 2002-06-11 2003-06-11 Gene cluster analysis for coronary artery disease Abandoned AU2003245438A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38761202P 2002-06-11 2002-06-11
US60/387,612 2002-06-11
PCT/US2003/018397 WO2003103480A2 (en) 2002-06-11 2003-06-11 Gene cluster analysis for coronary artery disease

Publications (2)

Publication Number Publication Date
AU2003245438A1 true AU2003245438A1 (en) 2003-12-22
AU2003245438A8 AU2003245438A8 (en) 2003-12-22

Family

ID=29736339

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003245438A Abandoned AU2003245438A1 (en) 2002-06-11 2003-06-11 Gene cluster analysis for coronary artery disease

Country Status (2)

Country Link
AU (1) AU2003245438A1 (en)
WO (1) WO2003103480A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6088300A (en) * 1999-07-12 2001-01-30 Gene Logic, Inc. Modulation of egr-1 and egr-2 in heart disease
US20020137081A1 (en) * 2001-01-08 2002-09-26 Olga Bandman Genes differentially expressed in vascular tissue activation

Also Published As

Publication number Publication date
AU2003245438A8 (en) 2003-12-22
WO2003103480A9 (en) 2004-06-10
WO2003103480A2 (en) 2003-12-18
WO2003103480A3 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
AU2002259250A1 (en) Model selection for cluster data analysis
AU2003299589A1 (en) A browsable database for biological use
AU2002249116A1 (en) Gene library for screening methods
AU2003241834A1 (en) Remedy for chronic disease
WO2004046979A8 (en) Risk data analysis system
AU2003202880A1 (en) Instrument cluster
AU2003265768A1 (en) Automated framework for the analysis of biological data
AU2002952938A0 (en) System for Conducting Clinical Trials
AU2003245035A1 (en) Disease predictions
AU2002339377A1 (en) Floor made from individual elements
AU2003273640A1 (en) Autism gene
AU2003262791A1 (en) OLIGONUCLEOTIDE TAGGED NUCLEOSIDE TRIPHOSPHATES (OTNTPs) FOR GENETIC ANALYSIS
AU2003223780A1 (en) Treatment for pompe disease
AU2003303869A1 (en) Methods for nucleic acid analysis
AU2003277202A1 (en) Methods for diagnosing bone turnover disease
AU2003266302A1 (en) Method for the diagnosis of alzheimer disease
AU2003260095A1 (en) Methods for recruiting patients for clinical studies
AU2003245438A1 (en) Gene cluster analysis for coronary artery disease
AU2003285583A1 (en) Oligonucleotide guided analysis of gene expression
AU2003296049A1 (en) Process control based on analysis of microbial populations
AU2003294206A1 (en) Methods for diagnosing htlv-i-mediated diseases
AU2003261366A1 (en) Methods for regulating brca1-brca2-containing complex activity
AU2003301587A1 (en) Method for diagnosing renal diseases or predispositions
AU2003293382A1 (en) Methods for identifying the activity of gene products
AU2002358532A1 (en) Method for analyzing translation-controlled gene expression

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase